Publications by authors named "Marcus Eich"

Claim this Profile
I
Impaired DNA repair in mouse monocytes compared to macrophages and precursors.
Nancy Berte, Marcus Eich, Daniel Heylmann, Carolien Koks, Stefaan W Van Gool

DNA Repair (Amst)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMIP-059: Identification of Mouse Hematopoietic Stem and Progenitor Cells with Simultaneous Detection of CD45.1/2 and Controllable Green Fluorescent Protein Expression by a Single Staining Panel.
Marcus Eich, Andreas Trumpp, Steffen Schmitt

Cytometry A· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, Andreas Acs, Dieter Adam, Marcus Eich

Eur J Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
Nancy Berte, Stefanie Lokan, Marcus Eich, Ella Kim, Bernd Kaina

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
Alonso Barrantes-Freer, Mirjam Renovanz, Marcus Eich, Alina Braukmann, Bettina Sprang

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts.
Jörg Fahrer, Johannes Huelsenbeck, Henriette Jaurich, Bastian Dörsam, Teresa Frisan, Marcus Eich

DNA Repair (Amst)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Marcus Eich, Wynand Paul Roos, Teodora Nikolova, Bernd Kaina

Mol Cancer Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Marcus Eich, Wynand P Roos, Grigory L Dianov, Martin Digweed, Bernd Kaina

Mol Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis